UPDATE: The response to the pilot testing has been outstanding. We are no longer accepting submissions.
Living Well With Epilepsy is partnering with Self Care Catalysts to build an epilepsy digital application. We are looking for volunteers to participate in a brief pilot test of the application. We need feedback from people living with epilepsy and from caregivers.
Your feedback is key
Some of you participated in the first round of feedback. Many of the suggestions you made have already been incorporated into the app as a result.The pilot test will give you a chance to try out the app. And, it will give us a chance to collect feedback on the features and functionality.
Pilot test kicks off
The team at Self Care Catalysts has scheduled two webinars on February 16, at Noon ET and 6pm ET. The webinar will serve as a brief tutorial on how to use the app. Participants will then take part in the pilot testing during which you will have a few days to use the app. Then the team will then follow up with participants on their experience.
Only a few spots available
If you are interested in participating, please complete the form below. After you submit the form, a member of the Self Care Catalysts team will contact you. Participation in the pilot test will be on a first come first serve basis.
Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.
Leave a Reply